Research
Molecular
Emerging pharmacologic agents and alternative approaches targeting obesity pathways are being explored.
Practitioners should stay informed about new pharmacologic agents and alternative approaches in obesity treatment.
StrongSupportsmedium confidence
Emerging pharmacologic agents and alternative approaches targeting these pathways and relevant research in both animals and humans are presented in detail.
Why this rating
The claim is based on a review of current research efforts.
Source
Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
Angeliki M. Angelidi et al. · Endocrine Reviews · 2021
DOI 10.1210/endrev/bnab034
reviewCited 121×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →